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Introduction
Large conductance Ca 2+ /voltage-activated K + (BK) channels are expressed in the plasma membranes and intracellular organelles of numerous cell types. 1 BK channels are important physiological regulators whose functions are impacted by and/or underlie disease. 2, 3 These channels are composed of pore-forming α subunits encoded by the KCNMA1 gene. 4 The minimal BK channel is an assembly of 4 α subunits around a central axis. Each α subunit has an extracellular N-terminus, 7 transmembrane segments, and an intracellular C-terminus containing numerous regulatory domains and sites. 5 α-only tetramers are fully functional K + -selective channels with inherent Ca 2+ -and voltage-sensitivity. Variations in α subunit properties result from alternative splicing of KCNMA1. 6 However, a variety of important post-translational modifications also regulate BK channel properties, including their trafficking and anchoring to the membrane. 7, 8 Other differences in BK channels can be due to co-assembly with regulatory β subunits, 4 of which have been identified. 9 β subunits can dramatically change channel properties including gating kinetics, Ca 2+ /voltage-sensitivity, and pharmacology. 10 Interestingly, it has been demonstrated recently that the N-terminus of intermediate conductance Ca 2+ -activated K + channels reduces BK channel NP o by the same open channel block underlying β2-and β3-induced inactivation. 11 β subunits can also influence the response of BK channels to pharmacological blockers and openers. [12] [13] [14] [15] BK channels are activated by estradiol 16 and xenoestrogens. 13, 17, 18 Regulation by estrogenic substances, in multiple cases, involves β subunits. 13, 16, 18 We demonstrated previously that BPA increases the open probability (NP o ) of BK channels without affecting single channel conductance. 19 BPA appears to have less of an effect on BK channels lacking the β1 subunit, as a 10-fold higher concentration of BPA was needed to activate BK α subunits alone. 19 Thus, effects of BPA, like those of other xenoestrogens, seem to be modulated by β subunits. However, a particular extracellular or intracellular binding site for the molecule has not been identified; BPA is lipophilic and it would be reasonable to suggest sites on either side of the membrane. It is possible that BPA binds to the α subunit, but this interaction is made much more efficient by addition of the β1 subunit. 19 Another possibility may be that 2 different BPA binding sites exist when the β1 subunit is present. 19 Whether these sites are intracellular, extracellular, or both remains unclear. In this study, we test the hypothesis that an extracellular binding site is responsible for activation of BK channels by BPA. In order to examine this possibility, we synthesized membrane-impermeant BPA-monosulfate (BPA-MS). This novel reagent allows us to determine whether an intracellular or extracellular binding site exists (under the presumptions that BPA-MS: [1] can bind to the same site(s) as BPA and [2] similarly increase channel activity). W-C, C-A, and I-O recordings were made on cells expressing BK channels composed of α or α + β1 subunits.
Results
We recorded BK currents in AD 293 cells expressing α or α + β1 subunits (Fig. 1) . Our goal was to determine whether BPA-MS, a membrane-impermeant derivative of BPA, increased whole-cell BK current. Further, if BPA-MS were to have an effect, we were interested in determining whether the presence of the β1 subunit influenced it. In cells expressing BK α subunits, wholecell current was unaffected by 10 μM BPA-MS ( Fig. 1A and B) . Specifically, in cells expressing α subunits alone, current in the presence of BPA-MS was 106 ± 4% of control (n = 5). There was no BK current in non-transfected cells (data not shown) and the current in transfected cells was identified as BK through its sensitivity to 1 μM penitrem A (93 ± 4% block). 12 In cells expressing BK α + β1 subunits, current magnitude was increased by 10 μM BPA-MS ( Fig. 1C and D) . Specifically, at +100 mV, BPA-MS increased current 34 ± 4% (an increase of 712 ± 103 pA; n = 7) when the β1 subunit was present. These data are very much like what we reported previously for the effect of BPA on whole-cell BK current and the role of the β1 subunit (ref. 19 ); however, these experiments with BPA-MS further indicate that the stimulatory effect of BPA is probably mediated, at least in part, by an extracellular binding site.
In our previous report, we demonstrated that a 10-fold higher concentration of BPA (100 μM) could activate BK channels composed of α subunits alone. 19 Thus, in the present study, we determined whether a log order higher concentration of membrane-impermeant BPA-MS (100 μM) could also activate BK α subunits (Fig. 2) . Bath application of 100 μM BPA-MS to W-C patches increased BK α current ( Fig. 2A) . Specifically, at +100 mV, 100 μM BPA-MS increased BK α current 36 ± 4% (an increase of 1151 ± 187 pA; n = 6). These data support what we demonstrated previously regarding the role of the β1 subunit in determining sensitivity to BPA. Further, these data lead us to suggest that the lower affinity site for activation of BK α by BPA/ BPA-MS is extracellular.
We performed additional W-C experiments to further characterize the concentration-dependence of BPA-MS effects (Fig. 3) . In cells expressing BK α + β1 subunits, BPA-MS increased current in a concentration-dependent manner (Fig. 3A) . The increase in BK α + β1 current by BPA-MS (Fig. 3B) was qualitatively similar to effects of BPA we reported previously. 19 Quantitatively, in cells expressing BK α + β1 subunits, the magnitude of BPA-MSactivated current was less than that elicited by BPA (Fig. 3B) . However, the current activated by BPA-MS was greater in cells expressing BK α + β1 subunits than cells expressing BK α alone (Fig. 3B) . These data may indicate that effects of BPA-MS are less than BPA because intracellular and extracellular binding sites exist, but bath-applied, membrane-impermeant BPA-MS is restricted to acting on only the extracellular site. Further, the data may indicate that BPA-MS is a more potent and efficacious agonist of BK channels when the β1 subunit is present. Our next set of experiments was designed to demonstrate that BPA-MS is, indeed, membrane-impermeant. Our rationale was that: (1) the W-C data suggest a low affinity extracellular site for BPA exists; (2) BPA is membrane-permeant and should activate channels in C-A patches through extracellular sites and intracellular sites (if any exist); (3) BPA-MS, if membrane-impermeant, should be unable to activate BK channels (α or α + β1) physically isolated from the test solutions by the pipette glass and plasma membrane. Results from C-A patches are shown in Figure 4 . In C-A patches on cells expressing BK α + β1, adding 10 μM BPA-MS to the bath had no effect on NP o (Fig. 4A) . In contrast, adding 10 μM BPA to the bath increased NP o 695 ± 325% (n = 8; Fig. 4A and B). We performed additional experiments with a higher concentration of BPA-MS (100 μM) to more rigorously test whether it might cross the membrane and activate channels. In C-A patches on cells expressing BK α + β1, adding 100 μM BPA-MS to the bath had no effect on channel activity (NP o was 132 ± 9% of control; n = 4). In contrast, adding 100 μM BPA to bath solution in these experiments increased NP o 521 ± 154% (P < 0.05). These data demonstrating differential effects of BPA and BPA-MS on NP o reassure us that the latter is likely membrane-impermeant (and that our preparation of BPA-MS is not contaminated with significant amounts of BPA). Further, the data also lead us to suggest that AD 293 cells do not metabolize BPA-MS by desulfation to produce BPA, as can be observed in cells expressing estrone sulfatase activity. 20 We excised I-O patches from cells expressing BK channels composed of α or α + β1 subunits and determined the effect of bath-applied BPA-MS (Fig. 5) . Our goal was to determine whether BPA-MS increased BK channel NP o at the intracellular face of the membrane. Further, if BPA-MS were to activate BK channels, we were interested in determining whether the presence of the β1 subunit influenced this effect. In I-O patches from cells expressing BK α alone, adding 100 μM BPA-MS to the bath had no significant effect on NP o (156 ± 15% of control, n = 8; Fig. 5A and B). However, adding 100 μM BPA to the bath increased NP o 462 ± 147% (Fig. 5A and B) . The response to intracellular BPA-MS was much different when BK channels contained the β1 subunit (Fig. 5C) . In I-O patches from cells expressing BK α + β1 subunits, adding 10 μM BPA-MS to the bath increased NP o 403 ± 97% (n = 15; Fig. 5C and D) . Replacing BPA-MS with BPA increased NP o 910 ± 247% (Fig. 5C and D) . Thus, BPA-MS can activate BK channels from the cytoplasmic face of the membrane only if the β1 subunit is present. These data lead us to suggest that the β1 subunit may comprise or complete an intracellular binding site for BPA.
Until this point, all of our single channel experiments had been performed at only 1 voltage, +40 mV on the membrane. We were interested in determining the effect of BPA-MS on BK channel activity at a variety of voltages. Rather than repeat the experiments outlined above at constant holding potentials, we opted to construct activation curves for channels in I-O patches (Fig. 6) . Thus, I-O patches were excised from cells expressing BK α or α + β1 and stepped to voltages between -40 and +140 mV in symmetrical 140 mM K + with 500 nM Ca 2+ . Currents were recorded under control conditions and with bath application of 100 μM BPA-MS or 100 μM BPA. Conductance (G) was calculated by dividing current by voltage; G was then normalized to the maximum for each patch (G max ). When BK channels were composed of α subunits alone, BPA-MS had no effect on the voltage at which 50% of the channels were activated (V½ = 98 ± 2 and 98 ± 2 mV, n = 8; Fig. 6A-C) . However, bath application of membrane-permeant BPA did increase channel activity at lower voltages (V½ = 82 ± 2 mV). The BPA-induced hyperpolarizing shift was parallel, as the slope factor (k) was not significantly altered (16 ± 2 for all 3 curves). When BK channels contained the β1 subunit, BPA-MS hyperpolarized the V½ (from 54 ± 2 to 34 ± 2 mV, n = 12; Fig. 6D-F) . Bath application of membrane-permeant BPA increased channel activity further (V½ = 17 ± 3 mV). The BPA-induced hyperpolarizing shift was parallel, as k was not significantly altered (20 ± 2, 18 ± 2, and 22 ± 3 for control, BPA-MS, and BPA, respectively). Data from these activation curves support the single channel experiments in that: (a) BPA, but not BPA-MS, activates BK α in I-O patches; (b) in I-O patches, BPA-MS activates BK channels containing the β1 subunit; (c) membrane-permeant BPA activates BK α + β1 more than BPA-MS. Further, these data indicate that BPA and BPA-MS activate BK channels over a much wider range of voltages than we had examined in the previous experiments.
Effects of BPA-MS on NP o are reversible (Fig. 7) . The results in Figure 7A are from a single I-O patch pulled from a cell expressing BK α + β1. NP o at +40 mV is plotted vs. time. BPA-MS increased channel activity, but channel activity returned to baseline upon washout. Thus, effects of BPA-MS mediated at the intracellular face of the membrane are reversible. Data from a representative W-C experiment are shown in Figure 7B and C. These data indicate that effect of BPA-MS to increase BK current from extracellular face of the membrane is also reversible. We reported previously that BPA had no effect on BK channel unitary conductance. 19 It appears that BPA-MS, at least from the cytoplasmic side, does not alter unitary conductance either (see Fig. 5 ; also a lack of effect can be inferred from Fig. 6 , where G is unaffected). However, to determine whether BPA-MS affected unitary conductance from the extracellular side of the membrane, we performed experiments in outside-out patches. Extracelllular BPA-MS had no effect on BK channel amplitude, as channels demonstrated conductances of 240 ± 10 and 241 ± 10 pS before and during exposure to 100 μM BPA-MS, respectively (n = 4).
Discussion
BPA, a component of polycarbonate plastic used in food and beverage containers, is an estrogenic endocrine disruptor found in the urine of > 95% of Americans. 21 We and others have demonstrated that a wide variety of ion channels (GABA receptors, nicotinic receptors, voltage-gated Na + channels, voltage-gated Ca 2+ channels, and BK channels) are targets of BPA. 19, [22] [23] [24] [25] [26] [27] Specifically, we have shown previously that BPA activates BK channels; however, channels containing regulatory β1 subunits were approximately 1 log-order more sensitive to BPA. 19 In the present study, we tested the hypothesis that an extracellular binding site is responsible for activation of BK channels by BPA. This hypothesis was based on previous studies indicating that membrane-impermeant estrogen and estrogen receptor modulators activate BK channels by binding to an extracellular site. 16, 17 In order to test the hypothesis, we synthesized membrane-impermeant BPA-MS and used patch clamp electrophysiology to study BK channels composed of α or α + β1 subunits in C-A, W-C, and I-O patches. Our 4 major findings included: (1) BK α was activated by extracellular 100 μM BPA-MS (Fig. 2) ; (2) the β1 subunit made BK channels 10x more sensitive to extracellular BPA-MS (Fig. 1) ; (3) BK channels containing the β1 subunit were activated by intracellular BPA-MS, whereas α only BK channels were not (Figs. 5 and 6); and (4) BPA was a more efficacious activator of BK α + β1 than was BPA-MS (Figs. 3, 5, and 6 ). These data lead us to conclude that the hypothesis is supported. That is, an extracellular binding site appears to be responsible, at least in part, for the activation of BK channels by BPA (and BPA-MS). Importantly, however, we did not predict that BPA-MS would activate BK α + β1 channels from the cytoplasmic face of the membrane or that a difference would exist in the magnitude of NP o responses to intracellular BPA and BPA-MS. These surprising findings lead us to suggest that the β1 subunit may also constitute at least a part of an intracellular binding site.
The idea that that the β1 subunit may contribute to an intracellular binding site gains support from a substantial and integrative body of work from Dopico and colleagues on lithocholate, a cholane-derived steroid.
14,28-31 Lithocholate activates smooth muscle BK channels from wild type, but not β1 subunit knockout mice.
14 The second transmembrane domain of β1 is critical for conferring sensitivity to lithocholate, especially residues T169, L172, and L173. [29] [30] [31] Membrane topology and computational modeling place these 3 residues in an intracellular-facing region where hydrogen bonding and hydrophobic interactions form a binding site. Whether this pocket is responsible for our observed effects of intracellular BPA on BK channels remains to be determined. However, this is our prediction as this site also mediates responses to the nonsteroidal BK channel opener HENA (3-hydroxyolean-12-en-30-oate). 28 There is a clear case for wanting to understand the effects of lithocholate on BK channels, as bile acids can be found in the circulation in high micromolar concentrations, dilate arterioles (including ileal vessels, which facilitates adsorption of fat), and reduce blood pressure. 32 There is no such thing as a "physiological" level of BPA, so the need to understand the effects of BPA on ion channels comes from a toxicology point of view. BPA, with an annual production over six billion pounds, is one of the highest volume chemicals worldwide. 33 BPA is used to manufacture polycarbonate plastics, including those for food and beverage containers, which represent the major sources of exposure for most people. In fact, the body fluids of > 95% of Americans test positive for BPA. 21 This may be cause for concern, because BPA has been identified as an estrogenic endocrine disruptor. Insight into the biologically relevant mechanisms of BPA began in 1993 with the observation that it was released from polycarbonate plastics during autoclaving and interfered with estrogen binding proteins in yeast. 34 The structure of BPA allows it to bind receptors in the human body normally occupied by steroids to exert its anti-androgenic and estrogenic effects. BPA interacts with nuclear estrogen receptors (ER) α and β, albeit with low affinity. 35 By doing so, BPA exerts its nuclear (i.e., genomic) effects. BPA also possesses the ability to alter estrogen signaling through 2 less conventional pathways. 36 Specifically, BPA can bind to membrane-bound ERα and a G protein-coupled ER (GPER). 37 Both membrane-bound ERα and GPER couple to non-genomic signaling pathways that have multiple effects, most of which have only recently become appreciated. 38 Ion channels are also targets for BPA effects. 19, [22] [23] [24] [25] [26] [27] Whether these ion channel effects contribute to the association of BPA exposure with disease remains to be determined. 39 The first identified ion channel target for BPA was recombinant GABA A receptors in 2001. 22 Complex effects were demonstrated, as low concentrations of BPA potentiated responses to low concentrations of GABA, but high concentrations of BPA inhibited GABA responses. Later, BPA was shown to elicit postsynaptic current in CA3 pyramidal neurons, likely mediated by GABA A channels. 23 The activation of GABA A channels by BPA may be interestingly related to mechanisms responsible for BK channel activation by BPA, as both channels are also potentiated by ethanol. 40 Effects of BPA on the other identified ion channel targets share a common feature, as BPA uniformly inhibits a variety of voltage-gated Na + channels (tetrodotoxin-sensitive and -resistant) and voltage-gated Ca 2+ channels (L-, N-, P/Q-, and T-type). 24, 26, 27 In contrast, we show that BPA activates BK channels, which, interestingly, share some structural and regulatory features of voltagegated Na + and Ca 2+ channels. Whether these non-genomic effects of BPA on BK channels (as well as other ion channels) are relevant to human disease remains to be determined. Genomic effects of BPA on ion channel expression are also possible and merit investigation. The present study, however, focused on non-genomic mechanisms and we have shown that 100 μM BPA-MS activated current in cells expressing α subunits, whereas cells expressing α + β1 subunits responded equally to 10 μM BPA-MS. The W-C data suggest that an extracellular site exists for BPA on the α subunit. Our data show that in I-O patches, where the cytoplasmic face was exposed to the bath, BPA-MS had no effect on the NP o of channels containing α alone; however, BPA-MS increased the NP o of BK channels composed of α + β1 subunits. These I-O data suggest that the β1 subunit completes or comprises an intracellular binding site for BPA. Together, the data lead us to conclude that BPA activates BK channels via an extracellular binding site and via an intracellular binding site that depends on the presence of the β1 subunit. We predict that the intracellular binding site may be the same one identified for interactions with lithocholate and HENA.
Methods

Cell culture and transfection
The techniques used here were similar to those we have used previously. 19 AD 293 cells (Agilent Technologies) were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 100 μg/ ml streptomycin. Culture flasks were incubated in a 5% CO 2 incubator, humidified, and kept at 37 °C. Plasmids encoding hSlo α and hSlo α + β1 were kindly provided by Dr Jonathan Lippiat (University of Leeds). 41 Cells were transiently transfected with pIRES-hSloα or pIRES-hSloαβ1 and pmaxGFP (AMAXA) using Lipofectamine LTX with PLUS reagent (Invitrogen). Cells at 50-70% confluence in 35-mm dishes were transfected with 0.5-2.5 μg of DNA. Transfected cells were selected in DMEM supplemented with 0.5 mg/ml G418, 1% fetal bovine serum, 100 U/ml penicillin, and 100 μg/ml streptomycin. Currents were recorded from cells expressing green fluorescent protein (GFP) 1-3 d later.
Electrophysiology BK channel currents were recorded at room temperature from inside-out (I-O), cell-attached (C-A), and whole-cell (W-C) patches as described previously. 12, 19 The bath flowed at a rate of approximately 2-3 ml/min into a chamber with a volume of approximately 0.2-0.3 ml throughout the recordings. For W-C recordings, bath solution contained (mM) 135 NaCl, 5 KCl, 2 CaCl 2 , 1 MgCl 2 , 10 glucose, 10 HEPES, and 5 Tris; pH 7.4. Chemicals were purchased from Fisher Scientific or Sigma-Aldrich. For W-C recordings, pipette solution contained (mM) 140 KCl, 1 MgCl 2 , 1 EGTA, 0.281 CaCl 2 , 1 Mg-ATP, 0.1 Na-GTP, 10 HEPES, and 5 Tris; pH 7.1; pCa 7. I-O and C-A recordings were made in symmetrical (mM) 140 KCl, 1 MgCl 2 , 1 EGTA, 10 HEPES, and 5 Tris; pH 7.1. CaCl 2 was added to these solutions to achieve free Ca 2+ concentrations of 100 nM (pCa 7; calculated using Maxchelator; http://www. stanford.edu/~cpatton/maxc.html) or 500 nM (pCa 6.3; calculated in ref. 42 ) as indicated for individual experiments. Because Cl -was symmetrical in all recording conditions, no adjustments were made for the negligible junction potentials. W-C and single channel pipettes were fashioned from borosilicate glass and had tip resistances of 2-3 and 5-10 MΩ, respectively. In W-C recordings, cell capacitance and series resistance were compensated as completely as possible by circuitry of the amplifier (Axopatch 200B; Molecular Devices). Currents were low pass filtered at 1 kHz and digitized at 5 kHz. pClamp 9 software was used for data acquisition and analysis (Molecular Devices).
Synthesis of BPA-MS BPA-MS was synthesized from BPA and SO 3 -pyridinium complex, as described previously. 20 BPA and 1.1 equivalents of SO 3 were stirred in dry pyridine under Ar for 36 h. Solvent was removed under reduced pressure and the crude reaction mixture was purified by column chromatography (10% methanol in CH 2 Cl 2 ). The pyridinium salt was dissolved in water and passed down a Dowex 50W X-8 cation exchange column, sodium form. Bonferroni post hoc tests followed 1RM-ANOVA and 2RM-ANOVA when appropriate to determine where differences existed. When only 2 values were compared, a paired Student t test was used. In all tests, P < 0.05 was considered significant.
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